Insulet (NSDQ:PODD) shares are up today after the insulin management company said its 3rd-quarter earnings topped expectations and named a new finance chief.
Insulet
Insulet CEO DeSisto steps down
Medtronic CEO Ishrak seeks to reassure employees on MDT-COV deal | The week in medtech M&A
Allergan CFO Edwards steps down amid hostile Valeant takeover bid | Personnel Moves
Diabetes and data: DexCom, Insulet share data in pursuit of app-based diabetes manager
Medtech leaders talk mistakes, challenges and opportunities at DeviceTalks
A group of medtech insiders gathered in Boston last night to talk shop, share stories and glean insight from some of the industry’s brightest minds at MassDevice’s DeviceTalks East conference.
Diabetes: Insulet settles Becton, Dickinson patent spat for $5M
Diabetes: Insulet, DexCom rekindle partnership with mobile app for OmniPod
Diabetes: Abbott recalls blood glucose meters over false readings
Updated March 17, 2014, at 4:30 pm. with comments from Abbott.